Autoimmune encephalitis: Early and late findings on serial MR imaging and correlation to treatment timepoints.

Autoimmune diseases Brain Encephalitis Magnetic resonance imaging

Journal

European journal of radiology open
ISSN: 2352-0477
Titre abrégé: Eur J Radiol Open
Pays: England
ID NLM: 101650225

Informations de publication

Date de publication:
Jun 2024
Historique:
received: 28 11 2023
revised: 26 01 2024
accepted: 29 01 2024
medline: 8 2 2024
pubmed: 8 2 2024
entrez: 8 2 2024
Statut: epublish

Résumé

MRI is negative in a large percentage of autoimmune encephalitis cases or lacks findings specific to an antibody. Even rarer is literature correlating the evolution of imaging findings with treatment timepoints. We aim to characterize imaging findings in autoimmune encephalitis at presentation and on follow up correlated with treatment timepoints for this rare disease. A full-text radiological information system search was performed for "autoimmune encephalitis" between January 2012 and June 2022. Patients with laboratory-identified autoantibodies were included. MRI findings were assessed in correlation to treatment timepoints by two readers in consensus. For statistical analysis, cell-surface vs intracellular antibody groups were assessed for the presence of early limbic, early extralimbic, late limbic, and late extralimbic findings using the χ Thirty-seven patients (female n = 18, median age 58.8 years; range 25.7 to 82.7 years) with 15 different autoantibodies were included in the study. Twenty-three (62%) patients were MRI-negative at time of presentation; 5 of these developed MRI findings on short-term follow up. Of the 19 patients with early MRI findings, 9 (47%) demonstrated improvement upon treatment initiation (7/9 cell-surface group). There was a significant difference (p = 0.046) between the MRI spectrum of cell-surface vs intracellular antibody syndromes as cell-surface antibody syndromes demonstrated more early classic findings of limbic encephalitis and intracellular antibody syndromes demonstrated more late extralimbic abnormalities. MRI can be used to help narrow the differential diagnosis in autoimmune encephalitis and can be used as a monitoring tool for certain subtypes of this rare disease.

Identifiants

pubmed: 38327544
doi: 10.1016/j.ejro.2024.100552
pii: S2352-0477(24)00007-8
pmc: PMC10847996
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100552

Informations de copyright

© 2024 The Authors.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Mahmoud Abunada (M)

Department of Neuroradiology, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Switzerland.

Nathalie Nierobisch (N)

Department of Neuroradiology, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Switzerland.

Riccardo Ludovichetti (R)

Department of Neuroradiology, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Switzerland.

Cyril Simmen (C)

Department of Neurology, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Switzerland.

Robert Terziev (R)

Department of Neurology, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Switzerland.

Claudio Togni (C)

Department of Neurology, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Switzerland.

Lars Michels (L)

Department of Neuroradiology, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Switzerland.

Zsolt Kulcsar (Z)

Department of Neuroradiology, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Switzerland.

Nicolin Hainc (N)

Department of Neuroradiology, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Switzerland.

Classifications MeSH